Professor Graham Scotland

Professor Graham Scotland
Professor Graham Scotland
Professor Graham Scotland

Personal Chair

About

Biography

Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.

Publications

Page 4 of 9 Results 31 to 40 of 81

  • Lanadelumab for preventing recurrent attacks of hereditary angioedema.

    Robertson, C., Walker, A., Jacobsen, E., Aucott, L., Herriot, R., Scotland, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports
  • Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer

    Robertson, C., Fielding, S., Walker, A., Kopasker, D., Vadiveloo, T., Manson, P., Price, G., Brazzelli, M., Scotland, G.
    Commissioned by National Institute for Health and Care Excellence. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports
  • Risankizumab for treating moderate to severe plaque psoriasis

    Imamura, M., Cooper, D., Hernández, R. A., Scotland, G., Ormerod, A., Brazzelli, M.
    Evidence Review Group report in support of NICE Fast Track Appraisal Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports
  • TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices.

    Hernández, R. A., Robertson, C., Scott, N., Scotland, G., Booth, C., Manson, P., Broadhurst, P., Brazzelli, M.
    National Institute for Health and Care Excellence (NICE)
    Books and Reports: Commissioned Reports
  • The ARCHITECT and Alinity urine NGAL assays, urine NephroCheck test, and urine and plasma NGAL tests to help assess the risk of acute kidney injury in people who are being considered for admission to critical care

    Brazzelli, M., Aucott, L., Aceves Martins, M., Robertson, C., Jacobsen, E., Imamura, M., Poobalan, A., Manson, P., Scotland, G., Kaye, C., Sawhney, S., Boyers, D.
    National Institute for Health and Care Excellence (NICE). 376 pages
    Books and Reports: Commissioned Reports
  • Dupilumab for treating adults with moderate to severe atopic dermatitis.

    Hernandez, R. A., Cruickshank, M., Dimitrova, M. P., Cooper, D. J., Aucott, L. S., Fraser, C., Shimonovich, M., Ormerod, A., Scotland, G. S., Brazzelli, M. G.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports
  • Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation

    Scotland, G., Cruickshank, M., Jacobsen, E., Cooper, D., Fraser, C., Shimonovich, M., Marks, A., Brazzelli, M.
    Health Technology Assessment, vol. 22, no. 1, pp. 1-138
    Contributions to Journals: Literature Reviews
  • HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial

    Cooper, K., McCormack, K., Breeman, S., Wood, J., Scott, N. W., Clark, J., Hawe, J., Hawthorn, R., Phillips, K., Hyde, A., McDonald, A., Forrest, M., Wileman, S., Scotland, G., Norrie, J., Bhattacharya, S., HEALTH Study Group
    Trials, vol. 19, 63
    Contributions to Journals: Articles
  • Teduglutide for treating short bowel syndrome

    Scotland, G., Kopasker, D., Scott, N., Cruickshank, M., Hernández, R. A., Fraser, C. M., McLean, M., McKinlay, A., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 142 pages
    Books and Reports: Commissioned Reports
  • A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol

    Denison, F. C., Norrie, J., Lawton, J., Norman, J. E., Scotland, G., McPherson, G. C., McDonald, A., Forrest, M., Hudson, J., Brewin, J., Peace, M., Clarkson, C., Brook-Smith, S., Morrow, S., Hallowell, N., Hodges, L., Carruthers, K. F.
    BMJ Open, vol. 7, e017134
    Contributions to Journals: Articles
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Contributions to Conferences

Contributions to Journals